KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $0.655 $0.83 Friday, 26th Apr 2024 DBVT stock ended at $0.682. This is 1.07% less than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 7.91% from a day low at $0.662 to a day high of $0.714.
90 days $0.655 $0.95
52 weeks $0.650 $2.37

Historical DBV Technologies S.A. prices

Date Open High Low Close Volume
Mar 07, 2016 $27.57 $30.55 $27.20 $30.11 785 800
Mar 04, 2016 $25.56 $26.69 $25.00 $26.15 471 800
Mar 03, 2016 $25.87 $25.87 $24.94 $25.27 72 100
Mar 02, 2016 $25.95 $26.08 $25.52 $25.97 58 000
Mar 01, 2016 $25.93 $26.20 $25.66 $26.08 277 600
Feb 29, 2016 $26.32 $26.33 $25.13 $25.15 312 300
Feb 26, 2016 $26.46 $26.68 $25.37 $25.70 120 600
Feb 25, 2016 $26.27 $26.51 $25.58 $25.60 79 200
Feb 24, 2016 $26.50 $26.50 $25.92 $26.03 120 700
Feb 23, 2016 $26.80 $27.29 $26.35 $26.43 106 500
Feb 22, 2016 $26.49 $26.89 $26.22 $26.37 50 800
Feb 19, 2016 $24.82 $25.67 $24.37 $25.61 31 000
Feb 18, 2016 $26.14 $26.21 $24.88 $25.04 70 100
Feb 17, 2016 $25.06 $25.98 $24.80 $25.24 150 600
Feb 16, 2016 $24.24 $24.39 $23.72 $23.83 91 300
Feb 12, 2016 $23.56 $23.58 $22.75 $23.32 151 800
Feb 11, 2016 $23.45 $23.74 $23.14 $23.37 121 000
Feb 10, 2016 $23.38 $23.45 $22.70 $23.14 85 500
Feb 09, 2016 $22.62 $23.50 $22.55 $23.02 89 600
Feb 08, 2016 $23.44 $23.45 $22.69 $23.20 215 000
Feb 05, 2016 $25.75 $25.83 $24.23 $24.26 226 400
Feb 04, 2016 $25.30 $26.36 $25.12 $26.34 93 600
Feb 03, 2016 $25.97 $26.13 $24.91 $26.12 157 200
Feb 02, 2016 $26.33 $26.39 $25.63 $25.81 72 300
Feb 01, 2016 $26.30 $26.66 $25.90 $26.63 88 100
Click to get the best stock tips daily for free!

About DBV Technologies S.A.

DBV Technologies S.A. DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents, and adults. The milk-induced company is also developing Viaskin Milk that is in Phase I/II clinical t... DBVT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT